» Articles » PMID: 16322695

Dissecting the Cellular Origins of Pancreatic Cancer

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2005 Dec 3
PMID 16322695
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Although putative premalignant lesions like metaplasia--the replacement of one mature cell type with another--have been identified in a variety of cancers, the normal cellular targets of malignant transformation are largely unknown. Pancreatic ductal adenocarcinoma (PDAC) is a particularly aggressive and lethal cancer. Despite its ductal histology, however, it is unknown whether PDAC originates from pancreatic ducts or another cell type within the pancreas. Recent analysis of mice with pancreas-specific deletion of the PTEN tumor suppressor gene has provided new insight into the mechanism of metaplasia and focuses attention on pancreatic centroacinar cells as candidates for the cellular origin of PDAC. Characterization of the "cell-of-origin" could lead to a better understanding of the molecular substrate for tumor initiation and eventually to early diagnosis and treatment.

Citing Articles

CFTR represses a PDX1 axis to govern pancreatic ductal cell fate.

Rotti P, Yi Y, Gasser G, Yuan F, Sun X, Apak-Evans I iScience. 2024; 27(12):111393.

PMID: 39687022 PMC: 11647141. DOI: 10.1016/j.isci.2024.111393.


Cell of Origin of Pancreatic cancer: Novel Findings and Current Understanding.

Zheng C, Wang J, Wang J, Zhang Q, Liang T Pancreas. 2024; 53(3):e288-e297.

PMID: 38277420 PMC: 11882172. DOI: 10.1097/MPA.0000000000002301.


Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer.

Sun Y, Ren D, Zhou Y, Shen J, Wu H, Jin X Cell Death Dis. 2021; 12(10):878.

PMID: 34564701 PMC: 8464605. DOI: 10.1038/s41419-021-04118-4.


Epithelial-Myeloid cell crosstalk regulates acinar cell plasticity and pancreatic remodeling in mice.

Zhang Y, Yan W, Mathew E, Kane K, Brannon 3rd A, Adoumie M Elife. 2017; 6.

PMID: 28980940 PMC: 5690281. DOI: 10.7554/eLife.27388.


Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9.

Makawita S, Dimitromanolakis A, Soosaipillai A, Soleas I, Chan A, Gallinger S BMC Cancer. 2013; 13:404.

PMID: 24007603 PMC: 3847832. DOI: 10.1186/1471-2407-13-404.